William Waterfield

1.4k total citations · 1 hit paper
13 papers, 1.1k citations indexed

About

William Waterfield is a scholar working on Oncology, Surgery and Immunology. According to data from OpenAlex, William Waterfield has authored 13 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 3 papers in Surgery and 3 papers in Immunology. Recurrent topics in William Waterfield's work include CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and Breast Cancer Treatment Studies (3 papers). William Waterfield is often cited by papers focused on CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and Breast Cancer Treatment Studies (3 papers). William Waterfield collaborates with scholars based in United States, Belgium and Italy. William Waterfield's co-authors include Jedd D. Wolchok, Axel Hoos, L. Thomas, Célèste Lebbé, Jose Lutzky, Dirk Schadendorf, Troy H. Guthrie, Jean‐Jacques Grob, Bart Neyns and Sylvie Négrier and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

William Waterfield

13 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

2009 934 citations Jedd D. Wolchok, Bart Neyns et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William Waterfield United States	7	997	497	245	153	76	13	1.1k
Veerle de Pril United States	13	1.3k 1.3×	653 1.3×	398 1.6×	154 1.0×	42 0.6×	26	1.5k
Gian Carlo Antonini Cappellini Italy	15	807 0.8×	259 0.5×	355 1.4×	261 1.7×	121 1.6×	25	1.1k
B. Rovati Italy	16	318 0.3×	265 0.5×	219 0.9×	76 0.5×	96 1.3×	38	651
Cécile Pagès France	19	794 0.8×	232 0.5×	302 1.2×	190 1.2×	39 0.5×	53	1.1k
N J Meropol United States	13	479 0.5×	257 0.5×	214 0.9×	140 0.9×	36 0.5×	21	774
Mark Cornfeld United States	11	497 0.5×	157 0.3×	294 1.2×	151 1.0×	112 1.5×	33	838
Alexandros Xyrafas Switzerland	16	766 0.8×	209 0.4×	185 0.8×	314 2.1×	267 3.5×	38	1.1k
Pamela Lockbaum United States	9	763 0.8×	93 0.2×	167 0.7×	222 1.5×	63 0.8×	13	983
Daan P. Hurkmans Netherlands	15	510 0.5×	196 0.4×	122 0.5×	164 1.1×	114 1.5×	27	700
Omar Hasan Ali Switzerland	12	498 0.5×	188 0.4×	125 0.5×	138 0.9×	35 0.5×	20	704

Countries citing papers authored by William Waterfield

Since Specialization

Citations

This map shows the geographic impact of William Waterfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Waterfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Waterfield more than expected).

Fields of papers citing papers by William Waterfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Waterfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Waterfield. The network helps show where William Waterfield may publish in the future.

Co-authorship network of co-authors of William Waterfield

This figure shows the co-authorship network connecting the top 25 collaborators of William Waterfield. A scholar is included among the top collaborators of William Waterfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Waterfield. William Waterfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Pennock, Gregory, William Waterfield, & Jedd D. Wolchok. (2011). Patient Responses to Ipilimumab, a Novel Immunopotentiator for Metastatic Melanoma. American Journal of Clinical Oncology. 35(6). 606–611. 65 indexed citations

Wolchok, Jedd D., Veerle de Pril, Gerald P. Linette, et al.. (2009). Efficacy of ipilimumab 10 mg/kg in advanced melanoma patients (pts) with good and poor prognostic factors. Journal of Clinical Oncology. 27(15_suppl). 9036–9036. 4 indexed citations

Wolchok, Jedd D., Bart Neyns, Gerald P. Linette, et al.. (2009). Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study. The Lancet Oncology. 11(2). 155–164. 934 indexed citations breakdown →

Averbach, Andrew, et al.. (2003). Results of curative therapy for esophageal cancer in a community training hospital.. PubMed. 87(1). 31–7. 3 indexed citations

Waterfield, William. (2002). Benchmarking as a means of improving the financial wellbeing of organic dairy farms. Organic Eprints (International Centre for Research in Organic Food Systems, and Research Institute of Organic Agriculture). 2 indexed citations

Rhodes, Deborah J., Rachel Cherian Koshy, William Waterfield, Albert W. Wu, & Stuart A. Grossman. (2001). Feasibility of Quantitative Pain Assessment in Outpatient Oncology Practice. Journal of Clinical Oncology. 19(2). 501–508. 47 indexed citations

Mikhak, Bahar, Marianna Zahurak, Martin D. Abeloff, et al.. (1999). Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinoma. Cancer. 85(4). 899–904. 3 indexed citations

Potter, Gene K., et al.. (1996). Metastatic Endometrial Adenocarcinoma to the Skin of a Toe. American Journal of Dermatopathology. 18(1). 94–98. 13 indexed citations

Waterfield, William, et al.. (1994). Neutropenia and fever in patients receiving chemotherapy in a community teaching hospital: results of a retrospective chart review.. PubMed. 43(11). 977–80. 2 indexed citations

10.

Waterfield, William & George A. Grierson. (1990). The lay of Alha : a saga of Rajput chivalry as sung by minstrels of northern India. 2 indexed citations

11.

Abeloff, Martin D., Roy Beveridge, Ross C. Donehower, et al.. (1990). Sixteen-Week Dose-Intense Chemotherapy in the Adjuvant Treatment of Breast Cancer. JNCI Journal of the National Cancer Institute. 82(7). 570–574. 33 indexed citations

12.

Markman, M, et al.. (1985). Intensive alternating chemotherapy regimen in small cell carcinoma of the lung.. PubMed. 69(2). 161–6. 23 indexed citations

13.

Waterfield, William, Charles K. Tashima, Gabriel N. Hortobágyi, et al.. (1978). Adriamycin and 1-(2-Chlorethyl)-3-Cyclohexyl-1-Nitrosourea (CCNU) in the treatment of metastatic breast cancer. Cancer. 41(4). 1235–1239. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact